TY - JOUR
T1 - Neurogenic inflammation in allergen-challenged obese mice
T2 - A missing link in the obesity-asthma association
AU - Ramalho, Renata
AU - Almeida, Joana
AU - Beltrão, Marília
AU - Pirraco, Ana
AU - Costa, Raquel
AU - Sokhatska, Oksana
AU - Guardão, Luísa
AU - Palmares, Carmo
AU - Guimarães, João Tiago
AU - Delgado, Luís
AU - Moreira, André
AU - Soares, Raquel
N1 - Funding Information:
This study was partially funded by FCT (PTDC/SAU-OSM/102083/2008, PEst-OE/SAU/UI0038/2011), and Fundac¸ão Professor Ernesto Morais, Portugal. Address correspondence to Renata Ramalho, Department of Immunology, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319, Porto, Portugal. E-mail: [email protected]
PY - 2012/8
Y1 - 2012/8
N2 - Aim: A number of studies have shown an association between obesity and asthma. Controversy remains on the mechanisms supporting this association. In this study we aimed to assess neurogenic inflammation in a model of diet-induced obesity and allergen-challenged mice. Methods: High fat diet-induced (HFD) obese Balb/c mice were sensitized and challenged with ovalbumin (OVA). Glucose, insulin, OVA-specific IgE and substance P (SP), and the main tachykinin involved in neurogenic inflammation, were quantified in sera. Cell counts were performed in bronchoalveolar lavage fluid (BALF). The extent of peribronchial infiltrates was estimated on lung tissue sections and inflammation was score based on inflammatory cell counts surrounding the bronchi. Results: Obesity per se and allergen-sensitization per se increased serum SP (P .027, P .004, respectively). Further increased was observed in obese-sensitized mice (P .007). Obese-sensitized mice also showed higher insulin (P .0016), OVA-specific IgE (P .016), peribronchial inflammatory score (P .045), and tendency for higher glycemia. The interaction of obesity and asthma on SP levels was confirmed (P .005, R 2 0.710). SP was positively correlated with metabolic (glycemia, r 0.539, P .007) and allergic inflammation parameters (BALF eosinophils, r 0.445, P 0.033; BALF mast cells, r 0.574, P .004; peribronchial inflammation score, r 0.661, P < .001; and OVA-specific IgE, r 0.714, P < .001). Conclusions: Our findings provide support to the neurogenic inflammation link between obesity and asthma in mice. These two conditions independently increased SP and the presence of both pathologies further increased this level. Neurogenic inflammation may be a previously unrecognized mechanism beyond the obese-asthma phenotype. Further studies are need to confirm this role of SP in human obesity-asthma association.
AB - Aim: A number of studies have shown an association between obesity and asthma. Controversy remains on the mechanisms supporting this association. In this study we aimed to assess neurogenic inflammation in a model of diet-induced obesity and allergen-challenged mice. Methods: High fat diet-induced (HFD) obese Balb/c mice were sensitized and challenged with ovalbumin (OVA). Glucose, insulin, OVA-specific IgE and substance P (SP), and the main tachykinin involved in neurogenic inflammation, were quantified in sera. Cell counts were performed in bronchoalveolar lavage fluid (BALF). The extent of peribronchial infiltrates was estimated on lung tissue sections and inflammation was score based on inflammatory cell counts surrounding the bronchi. Results: Obesity per se and allergen-sensitization per se increased serum SP (P .027, P .004, respectively). Further increased was observed in obese-sensitized mice (P .007). Obese-sensitized mice also showed higher insulin (P .0016), OVA-specific IgE (P .016), peribronchial inflammatory score (P .045), and tendency for higher glycemia. The interaction of obesity and asthma on SP levels was confirmed (P .005, R 2 0.710). SP was positively correlated with metabolic (glycemia, r 0.539, P .007) and allergic inflammation parameters (BALF eosinophils, r 0.445, P 0.033; BALF mast cells, r 0.574, P .004; peribronchial inflammation score, r 0.661, P < .001; and OVA-specific IgE, r 0.714, P < .001). Conclusions: Our findings provide support to the neurogenic inflammation link between obesity and asthma in mice. These two conditions independently increased SP and the presence of both pathologies further increased this level. Neurogenic inflammation may be a previously unrecognized mechanism beyond the obese-asthma phenotype. Further studies are need to confirm this role of SP in human obesity-asthma association.
KW - Asthma
KW - Neurogenic inflammation
KW - Obesity
KW - Specific IgE
KW - Substance P
UR - http://www.scopus.com/inward/record.url?scp=84862873156&partnerID=8YFLogxK
U2 - 10.3109/01902148.2012.699589
DO - 10.3109/01902148.2012.699589
M3 - Article
C2 - 22734814
AN - SCOPUS:84862873156
SN - 0190-2148
VL - 38
SP - 316
EP - 324
JO - Experimental Lung Research
JF - Experimental Lung Research
IS - 6
ER -